Sector Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
06:00:02 29/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 291.50 USD | -1.66% |
|
-1.25% | +46.13% |
| 21/08 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 20/08 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.66% | -1.25% | +24.24% | +61.31% | +46.13% | +78.49% | +39.02% | -34.45% | +245.95% | 13.92B | |
| -0.60% | -1.29% | +3.20% | +16.93% | +7.88% | +1.61% | +18.67% | -25.14% | +211.27% | 50.47B | |
| -6.00% | -0.75% | +8.18% | +32.00% | +160.99% | +447.48% | +524.26% | +633.26% | - | 44.56B | |
| -0.24% | +0.74% | +10.08% | +43.65% | +16.12% | +37.18% | +16.57% | +0.06% | +239.32% | 43.08B | |
| -1.55% | -2.07% | +13.86% | +27.37% | +20.71% | +19.83% | +73.63% | +21.51% | +1,153.78% | 41.7B | |
| -0.31% | -0.83% | +0.37% | +3.80% | +10.63% | +19.47% | +48.24% | -20.29% | +156.02% | 33.21B | |
| -1.79% | -3.24% | +3.86% | +34.34% | +6.94% | +26.32% | +121.63% | +225.54% | +2,055.96% | 16.77B | |
| -0.58% | -2.12% | -1.26% | +10.62% | - | - | - | - | - | 16.28B | |
| -0.14% | -1.37% | +6.02% | +16.81% | +15.80% | +11.20% | +27.13% | -39.82% | +98.84% | 14.58B | |
| +0.18% | -1.28% | +2.71% | +24.95% | -6.70% | -4.45% | -35.99% | -33.63% | +121.52% | 13.12B | |
| -9.41% | -11.90% | +44.59% | +26.89% | +8.45% | -15.58% | - | - | - | 11.56B | |
| -0.17% | +0.04% | +0.44% | +40.00% | +23.02% | +32.44% | -9.83% | -42.79% | +176.94% | 11.35B | |
| -2.93% | -8.75% | +21.58% | +74.42% | +53.99% | +44.68% | +44.68% | -49.62% | - | 10.96B | |
| -0.36% | -1.12% | -8.75% | -13.24% | -19.44% | +43.92% | +454.29% | +209.41% | +2,325.00% | 10.58B | |
| +0.01% | +0.16% | +0.50% | +64.32% | +78.82% | +271.10% | +464.73% | - | - | 10.18B | |
| -2.21% | +2.19% | +14.58% | -20.20% | -22.83% | +43.19% | +50.48% | +55.98% | +105.62% | 10.15B | |
| -1.73% | -1.38% | +10.41% | +45.11% | +51.84% | +186.77% | +503.11% | +93.31% | - | 9.82B | |
| -3.71% | +3.37% | +86.71% | +176.85% | +171.50% | +90.19% | +83.46% | -8.74% | +1,446.79% | 9.77B | |
| -6.28% | -8.30% | +12.02% | -1.49% | +16.97% | +657.03% | +1,553.48% | +20.52% | - | 9.63B | |
| -3.46% | -6.47% | +4.10% | +44.97% | +65.25% | +144.42% | +624.18% | +208.66% | +1,219.29% | 9.34B | |
| Average | -2.15% | -2.22% | +12.87% | +35.47% | +37.16% | +112.38% | +255.65% | +71.40% | +735.10% | 19.55B | |
| Weighted average by Cap. | -1.95% | -1.72% | +10.17% | +30.87% | +39.11% | +105.31% | +190.44% | +96.85% | +605.65% |
- Stock Market
- Stocks
- CRL Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
